MDNews - Mid Penn

FE ATURES WHEN TESTS COLLIDE: PERSPECTIVES ON LIQUID VS. TISSUE BIOPSIES 04 Divergent research findings have fueled questions about the comparative benefits of liquid and tissue biopsies. LANCASTER GENERAL HEALTH COLLABORATING FOR CARE-ENHANCING, COST-EFFECTIVE INNOVATION 07 Lancaster General Health leverages extensive clinical expertise in a Smart Health Innovation Lab in order to speed deployment of technologies that lower costs, enhance population health and the patient experience, and reduce provider burden. STEM CELL-DERIVED ß-CELLS HOLD PROMISE OF ADVANCING DIABETES CARE 09 Research at Penn State Hea lth Milton S. Hershey Medica l Center is leading to the development of stem cell-derived ß-cells with the potentia l to revolutionize diabetes treatment for millions. MRI-GUIDED LASER ABLATION EXPANDS OPTIONS FOR BRAIN TUMOR TREATMENT 10 The adoption of MRI-guided laser ablation gives Penn State Neuroscience Institute surgeons an innovative tool in the treatment of brain tumors. IMPROVING QUALITY OF LIFE FOR PATIENTS WITH INTRACTABLE PAIN 11 Hershey Medica l Center o‡ers dorsa l root ganglion stimulation therapy as an e‡ective a lternative for patients with complex regiona l pain syndrome and periphera l causa lgia who do not gain adequate pain control through conventiona l means. 18 contents /////// INNOVATION 2017 NEW LEADLESS PACEMAKER INCREASES OPTIONS FOR PATIENTS WITH HEART RHYTHM DISORDERS 12 The Micra, which is implanted into the heart by cardiac electrophysiologists at Penn State Heart and Vascular Institute, helps reduce or eliminate risks such as lead dislodgement and infection. UPMC PINNACLE LEVERAGES ADVANCED TECHNIQUES FOR EARLY DETECTION AND TREATMENT OF LUNG CANCER IN HIGH-RISK PATIENTS 15 Leading-edge techniques for early detection as well as state- of-the-art robotic and other technologies a llow lung cancer patients at UPMC Pinnacle to receive high-level treatment without leaving the area. ROBOTIC PCI AT WELLSPAN YORK HOSPITAL: ADVANCING PATIENT OUTCOMES, FOSTERING SAFETY FOR PATIENTS AND PROVIDERS 16 Robotic percutaneous coronary intervention reduces radiation exposure and physica l strain for physicians, while promising improved outcomes by enhancing techniques with the possibility of remote procedures in the future. BUILDING ON THE PROMISE OF RADIOEMBOLIZATION WITH YTTRIUM-90 18 Scientists are studying innovative ways to expand the uses of y ttrium-90 radioembolization beyond liver cancer treatment. DEPARTMENTS PRACTICE MANAGEMENT 13 PRODUCT SPOTLIGHT 14 04

• Cover